Novartis, 2 Generics Drop Lotrel Patent Lawsuits
Novartis AG and two generic-drug makers have agreed to dismiss without prejudice a total of four patent lawsuits in which the U.S. arm of the Switzerland-based pharmaceutical giant had said applications...To view the full article, register now.
Already a subscriber? Click here to view full article